Purinergic mechanisms in inflammation
- 1 November 1996
- journal article
- Published by Wiley in Drug Development Research
- Vol. 39 (3-4) , 426-435
- https://doi.org/10.1002/(sici)1098-2299(199611/12)39:3/4<426::aid-ddr24>3.0.co;2-y
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Adenosine: a sensitive marker of myocardial ischaemia in manCardiovascular Research, 1994
- The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.Journal of Clinical Investigation, 1993
- Modulation of Vasopressin Actions on Human Platelets by Plasma Adenosine and TheophyllineJournal of Cardiovascular Pharmacology, 1993
- Inflammatory injury in myocardial ischaemiaClinical Science, 1992
- Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells.Proceedings of the National Academy of Sciences, 1991
- Alteration of purine metabolism by AICA-riboside in human B lymphoblastsArchives of Biochemistry and Biophysics, 1990
- The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively.Journal of Clinical Investigation, 1990
- Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.Journal of Clinical Investigation, 1986
- Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.The Journal of Experimental Medicine, 1983
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962